Evidence map›Paper›PMID 36101675›Full record

ArticlePublic health in practice (Oxford, England)2020

The Lower-Risk Cannabis Use Guidelines (LRCUG): A ready-made targeted prevention tool for cannabis in New Zealand.

Benedikt Fischer, Dimitri Daldegan-Bueno, Ross Bell, Joseph M Boden, Chris Bullen, Michael Farrell, Wayne Hall, David Newcombe

Abstract read
In one paragraph

Article in Public health in practice (Oxford, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Benedikt FischerSchool of Population Health, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Dimitri Daldegan-BuenoSchool of Population Health, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Ross BellNew Zealand Drug Foundation, Wellington, New Zealand.
Joseph M BodenDepartment of Psychological Medicine, University of Otago, Christchurch, New Zealand.
Chris BullenSchool of Population Health, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Michael FarrellNational Drug and Alcohol Research Centre (NDARC), University of New South Wales, Sydney, Australia.
Wayne HallCentre for Youth Substance Abuse, Faculty of Health and Behavioural Sciences, Queensland University, Brisbane, Australia.
David NewcombeSchool of Population Health, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cannabis use is common, especially among young people, and associated with risks for select acute and chronic adverse health and social outcomes. New Zealand features overall high cannabis use levels, yet may soon follow other jurisdictions and implement legalization of non-medical cannabis use and supply towards public health objectives. While existing cannabis-oriented interventions mainly focus on primary prevention and treatment (e.g., for dependence), key harms from use are crucially influenced by risk factors that can be modified by the user. On this basis, and similar to other health behavior-oriented interventions, 'Lower-Risk Cannabis Use Guidelines' (LRCUG), consisting of 10 recommendation clusters for lower-risk use, were systematically developed in Canada as an evidence-based, targeted prevention tool towards reducing adverse outcomes among cannabis users. We briefly summarize the concept of and experiences with implementation of the LRCUG elsewhere, and describe how their adoption as a population health intervention may serve public health goals of possible cannabis legalization in New Zealand and elsewhere.

Indexed as

CannabisHealth behaviorLegalizationPreventionPublic healthRisk

Identifiers

PMID36101675
PMCPMC9461312

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.